Brown-Forman Corporation
NYSE:BF-BBeverages - Wineries & Distilleries
-$1.10 today
- Market cap
- $14.27B
- Beta
- 0.35
- P/E (TTM)
- 16.4
- EPS (TTM)
- $1.56
- Dividend yield
- 3.61%
Volume 2.06M
Average 4.64M
BF-B Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Brown-Forman CorporationNYSE: BF-B
Research & Development · Q1 FY2027 · quarter ended Jul 2026
Research & development remains negative
Q1 FY2027 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-04-30 | 0 | — |
| FY2025 | 2025-04-30 | 0 | — |
| FY2024 | 2024-04-30 | 0 | — |
| FY2023 | 2023-04-30 | 0 | — |
| FY2022 | 2022-04-30 | 0 | — |
Research & Development vs competitors
How BF-B compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for BF-B, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $0 USD | — | — | 0.0% | |
| FY2025 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | R$0 BRL | — | — | 0.0% | |
| LTM Aug 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding BF-B) | — | — | — | 0.0% | |
Competitors are the stored peer set for BF-B. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Apr 2022 | FY2023 Apr 2023 | FY2024 Apr 2024 | FY2025 Apr 2025 | FY2026 Apr 2026 |
|---|---|---|---|---|---|
| Revenue | 3.93B | 4.23B | 4.18B | 3.98B | 3.93B |
| Cost of Revenue | 1.54B | 1.73B | 1.65B | 1.63B | 1.55B |
| Gross Profit | 2.39B | 2.49B | 2.53B | 2.34B | 2.38B |
| Gross Margin | 60.8% | 59.0% | 60.5% | 58.9% | 60.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.13B | 1.25B | 1.36B | 1.23B | 1.27B |
| Operating Expenses | 1.19B | 1.37B | 1.38B | 1.18B | 1.27B |
| Depreciation & Amortization | 79M | 80M | 87M | 87M | 92M |
| EBITDA | 1.28B | 1.19B | 1.51B | 1.29B | 1.2B |
| EBITDA Margin | 32.4% | 28.1% | 36.2% | 32.5% | 30.6% |
| Operating Income | 1.2B | 1.13B | 1.15B | 1.17B | 1.11B |
| Operating Margin | 30.6% | 26.7% | 27.5% | 29.4% | 28.2% |
| Interest Income | 5M | 9M | 14M | 17M | 0 |
| Interest Expense | 82M | 90M | 127M | 122M | 89M |
| Other Income / Expenses | (90M) | (110M) | 151M | (86M) | (224M) |
| Income Before Tax | 1.11B | 1.02B | 1.3B | 1.08B | 885M |
| Pre-Tax Margin | 28.3% | 24.1% | 31.1% | 27.2% | 22.5% |
| Income Tax Expense | 276M | 234M | 274M | 212M | 170M |
| Net Income | 838M | 783M | 1.02B | 869M | 715M |
| Net Margin | 21.3% | 18.5% | 24.5% | 21.9% | 18.2% |
| EPS (Basic) | 1.75 | 1.63 | 2.15 | 1.84 | 1.53 |
| EPS (Diluted) | 1.74 | 1.63 | 2.15 | 1.84 | 1.53 |
| Weighted Avg Shares | 478.88M | 479.16M | 476.39M | 472.66M | 466.34M |
| Weighted Avg Shares (Diluted) | 480.57M | 480.57M | 477.22M | 472.95M | 466.73M |
Brown-Forman Corporation
NYSE:BF-B
Intrinsic Alpha fair value
Locked
Current Price
$30.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.